Kyocera Document Solutions Inc. Selects Anaqua for Integrated IP Management

BOSTON, June 14, 2022 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property management solutions, today announced that global document solutions provider Kyocera Document Solutions Inc. has selected Anaqua's AQX platform for integrated management of the company's extensive patent portfolio.

Headquartered in Osaka, Japan, Kyocera Document Solutions Inc. provides customers worldwide with a range of products, business applications, and consultative services to optimize and manage their document workflow, greatly enhancing operational efficiency.

Kyocera Document Solutions Inc. chose Anaqua's AQX Corporate platform as its primary patent management system with patent annuity payments from Anaqua Services fully integrated to unify patent management and payment management. Through this integrated functionality of the AQX Corporate platform and the availability of detailed, up–to–the–minute data visualization dashboards, Kyocera Document Solutions Inc. will be able to better manage, maintain and optimize the value of its portfolio.

"We were looking for an integrated approach that would enable us to manage our patent portfolio more efficiently and holistically," said General Manager of Legal and Intellectual Property Division, Seitaro Yoshida of Kyocera Document Solutions Inc. "AQX's comprehensive intellectual property management platform enabled global IP management for us. During implementation, Anaqua and Kyocera Document Solutions Inc. worked closely together to build up a new workflow. Anaqua listened and were responsive to our needs, enabling us to achieve the best fit for our operations."

"We are delighted to have been selected by Kyocera Document Solutions Inc. to help them manage their IP as the company continues in its goal of helping other organizations around the world put knowledge to work to drive change," said Bob Romeo, CEO of Anaqua. "The agreement not only reflects our strength in the business solutions sector, but also our increasing role in the Japanese market, where more and more companies are entrusting Anaqua with their IP management."

About Anaqua
Anaqua, Inc. is a premium provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX and PATTSY WAVE, both offer best practice workflows with big data analytics and tech–enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision–making, and streamline IP operations, tailored to each segment's need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua's solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company's global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia. For additional information, please visit anaqua.com, or on LinkedIn.

About Kyocera Document Solutions Inc.
Kyocera Document Solutions Inc. is a global leading provider of total document solutions based in Osaka, Japan. The company's portfolio includes reliable and eco–friendly MFPs and printers, as well as business applications and consultative services which enable customers to optimize and manage their document workflow, reaching new heights of efficiency. With professional expertise and a culture of empathetic partnership, the objective of the company is to help organisations put knowledge to work to drive change.

Kyocera Document Solutions Inc. is a group company of Kyocera Corporation (Kyocera), a leading supplier of semiconductor packages, industrial and automotive components, semiconductor packages, electronic devices, smart energy systems, printers, copiers, and mobile phones. During the year ended March 31, 2022, the Kyocera Group's consolidated sales revenue totaled 1.8 trillion yen (approx. US$15.1 billion). Kyocera is ranked #665 on Forbes magazine's 2022 "Global 2000" list of the world's largest publicly traded companies, and has been named by The Wall Street Journal among "The World's 100 Most Sustainably Managed Companies."

Company Contact:
Amanda Hollis
Communications Director
Anaqua
617–375–2626
ahollis@Anaqua.com


ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Riskified Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 1 Deadline in Securities Class Action – RSKD

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Riskified Ltd. (NYSE: RSKD) pursuant and/or traceable to the Registration Statement issued in connection with the Company's initial public offering conducted on or about July 28, 2021 (the "IPO" or "Offering"), of the important July 1, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Riskified securities pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Riskified class action, go to https://rosenlegal.com/submit–form/?case_id=5896 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 1, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the IPO Registration Statement was negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Specifically, the IPO Registration Statement made inaccurate statements of material fact because they failed to disclose the following adverse facts that existed at the time of the IPO: (1) as Riskified expanded its user base, the quality of Riskified's machine learning platform had deteriorated (rather than improved as represented in the Registration Statement), because of, among other things, inaccuracies in the algorithms associated with onboarding new merchants and entering new geographies and industries; (2) Riskified had expanded its customer base into industries with relatively high rates of fraud "" including partnerships with cryptocurrency and remittance business "" in which Riskified had limited experience and that this expansion has negatively impacted the effectiveness of Riskified's machine learning platform; (3) as a result, Riskified was suffering from materially higher chargebacks and cost of revenue and depressed gross profits and gross profit margins during its third fiscal quarter of 2021; and (4) thus, the Registration Statement's representations regarding Riskified's historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of Riskified prior to and at the time of the IPO, and were materially false and misleading, and lacked a factual basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Riskified class action, go to https://rosenlegal.com/submit–form/?case_id=5896 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Pegasystems Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PEGA

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pegasystems Inc. (NASDAQ: PEGA) between May 29, 2020 and May 9, 2022, both dates inclusive (the "Class Period"), of the important July 18, 2022 lead plaintiff deadline.

SO WHAT: If you purchased PEGA securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the PEGA class action, go to https://rosenlegal.com/submit–form/?case_id=6286 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 18, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) PEGA had engaged in corporate espionage and misappropriation of trade secrets to better compete against Appian; (2) Defendants' product development and associated success was, in significant part, not the result of its own research and product testing but rather the result of such corporate espionage and trade secret theft; (3) Defendants had engaged in a scheme to steal Appian trade secrets, which was not only known to, but carried out through the personal involvement of PEGA's CEO; (4) PEGA's CEO and other officers and employees did not comply with PEGA's written Code of Conduct; (5) PEGA was "unable to reasonably estimate damages" in the Appian Litigation; and (6) as a result of the foregoing, Defendants' statements about PEGA's business, operations, prospects, legal compliance, and potential damages exposure in the Appian Litigation were materially false and/or misleading and/or lacked a reasonable basis when made.

The truth regarding PEGA's fraudulent conduct was revealed after the close of the markets on May 9, 2022, when PEGA issued a press release announcing that the jury in the Appian Litigation had awarded Appian more than $2 billion for PEGA's misappropriation of trade secrets. In response to this news, PEGA's stock price fell 21%, from a closing price of $65.93 per share on May 9, 2022, to a closing price of $52.25 on May 10, 2022. As the market continued to digest the verdict, PEGA's stock price dropped another 8% to close at $48.07 per share the following day.

To join the PEGA class action, go to https://rosenlegal.com/submit–form/?case_id=6286 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Oscar Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OSCR

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Oscar Health, Inc. (NYSE: OSCR) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's March 2021 initial public offering ("IPO" or the "Offering"), of the important July 11, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Oscar securities pursuant and/or traceable to the Registration Statement you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit–form/?case_id=6200 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Registration Statement was materially false and misleading and omitted to state that: (1) Oscar was experiencing growing COVID–19 testing and treatment costs; (2) Oscar was experiencing growing net COVID–19 costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation (RADV) result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant Special Enrollment Period (SEP) membership growth; and (5) as a result of the foregoing, defendants' positive statements about Oscar's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Oscar class action, go to https://rosenlegal.com/submit–form/?case_id=6200 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Waste Management, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WM

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Waste Management, Inc. (NYSE: WM) redeemable senior notes (the "Notes") between February 13, 2020 and June 23, 2020, inclusive (the "Class Period"). The Notes include the following senior redeemable notes issued by WM in May 2019: (i) 2.95% Senior Notes due 2024; (ii) 3.20% Senior Notes due 2026; (iii) 3.45% Senior Notes due 2029; and (iv) 4.00% Senior Notes due 2039. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2022.

SO WHAT: If you purchased Waste Management Notes during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Waste Management class action, go to https://rosenlegal.com/submit–form/?case_id=6891 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the DOJ had indicated to Waste Management that it would require Waste Management to divest significantly more assets than the $200 million Antitrust Revenue Threshold; (2) as a result, the merger would not be completed by the End Date; and (3) the Notes would be subject to mandatory redemption at 101% of par.

To join the Waste Management class action, go to https://rosenlegal.com/submit–form/?case_id=6891 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


Reinforcing Success – Fluidic Propulsive System™ Development & New Crowdfunding Initiative

EDMONDS, Wash., June 14, 2022 (GLOBE NEWSWIRE) — Today, Jetoptera announced the launch of their Regulation Crowdfunding raise via StartEngine. We are creating a transformative aerospace propulsion system and capability to evolve vertical takeoff and landing aircraft beyond propellers and rotors.

Jetoptera invites you to be the catalyst, a pioneer, and adventurer with us on this amazing journey to bring forth a safe, quiet multi–use method of propulsion which is focused on S/VTOL, small and medium helicopter replacement with missions spanning logistics, air ambulance, VIP transportation and commonplace aerial mobility, as well as on high–speed VTOL, and wing in ground effect maritime craft, that can scale to a vast array of sizes and applications.

"We are encouraged and enthusiastic about the extensive data we are collecting with the support of the US Air Force to refine the design of our new scalable prototype FPS based vehicles," said Founder and CEO Dr. Andrei Evulet. "Advancements in such a transformational capability as Fluidic Propulsive Systems and their integration into advanced airframe designs demands our attention, focus and determination to make FPS propelled vehicles in the air, land and sea commonplace in the years to come."

To learn more about your Jetoptera Crowdfunded investment opportunity, please go to https://www.startengine.com/jetoptera/

ABOUT JETOPTERA
Jetoptera is a propulsion system, drone, and aerial mobility startup with the vision to create a world where aerial mobility is commonplace. To that end, we have developed and demonstrated a unique Fluidic Propulsive System integrated with a novel airframe, protected by 60 granted and allowed patents and another 100+ pending. This has many advantages over other approaches: faster, simpler, quieter, more compact, and lower cost. Our distributed propulsion system lends itself naturally to our mission, to create vertical and short takeoff and landing (V/STOL) aircraft, with other applications such as wing in ground effect vehicles to enable unmatched speed, range, payload, and efficiency to transport cargo and people.

Contact
Todd Newton
Vice President
+1 (703) 589–3739
info@jetoptera.com

Facebook | LinkedIn


ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Enservco Corporation Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – ENSV

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enservco Corporation (NYSE American: ENSV) between May 13, 2021 and April 18, 2022, both dates inclusive (the "Class Period"), of the important July 19, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Enservco securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Enservco class action, go to https://rosenlegal.com/submit–form/?case_id=6371 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Enservco had defective disclosure controls and procedures and internal control over financial reporting; (2) as a result, there were errors in Enservco's financial statements relating to, inter alia, its transactions with Cross River Partners and accounting for Employee Retention Credits ("ERCs"); (3) accordingly, Enservco would need to restate certain of its financial statements and delay the filing of its 2021 annual report with the U.S. Securities and Exchange Commission ("SEC"); (4) Enservco downplayed the true scope and severity of its financial reporting issues; (5) accordingly, Enservco could not file its delayed 2021 annual report with the SEC within its initially represented timeline; and (6) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Enservco class action, go to https://rosenlegal.com/submit–form/?case_id=6371 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


Elder Abuse: Human Rights Have an Expiration Date

The United Nations expects an increase in elder abuse because of the ageing populations: the global population of people aged 60 years and older will more than double, from 900 million in 2015 to 2 billion in 2050. Credit: Maricel Sequeira/IPS

The United Nations expects an increase in elder abuse because of the ageing populations: the global population of people aged 60 years and older will more than double, from 900 million in 2015 to 2 billion in 2050. Credit: Maricel Sequeira/IPS

By María Isabel Cartón
MADRID, Jun 14 2022 – 1 in 6 people over 60 years of age –nearly 141 million people globally– suffers from abuse, according to World Health Organization (WHO) estimates.

The World Elder Abuse Awareness Day (WEAAD) (June 15th), aims to raise awareness and eradicate this problem that affects both developing and developed countries.

WHO defines elder abuse as “a single, or repeated act, or lack of appropriate action, occurring within any relationship, where there is an expectation of trust, which causes harm or distress to an older person.” It can take various forms: physical, psychological or emotional, sexual, financial abuse or neglect

WHO defines elder abuse as “a single, or repeated act, or lack of appropriate action, occurring within any relationship, where there is an expectation of trust, which causes harm or distress to an older person.” It can take various forms: physical, psychological or emotional, sexual, financial abuse or neglect.

The lack of accurate data is one of the symptoms of this problem, but a 2017 review of 52 studies in 28 countries from diverse regions provided the pooled prevalence of different types of abuse:

– Psychological abuse: 11.6%

– Financial abuse: 6.8%

– Neglect: 4.2%

– Physical abuse: 2.6%

– Sexual abuse: 0.9%

 

The abusers

This violence happens at home and at institutions such as nursing homes and long-term care facilities. A staggering fact: 90% of abusers are family (adult children, spouses and partners).

But anybody can fit the abuser profile: relatives, strangers, friends, health care providers, public and private institutions… Whoever interacts with older people, especially with those who suffer a severe disability (i.e. dementia), can easily become abusers.

 

Why is that?

HelpAge International points out ageism. “Stereotypes about older people can be used to justify elder abuse or minimise its impact. In many ways, elder abuse is the most harmful expression of societal ageism”.

The normalization of this violence is a mask that makes it invisible or even an accepted or necessary conduct. So, how can we even identify it? Here are some examples:

Physical abuse: hitting, pushing and restraining by physical (tying them to furniture) and chemical means (medication). Also sexual abuse.

Emotional or psychological abuse: use of hurtful words, yelling, threatening or repeatedly ignoring the older adult. Isolation, infantilization and victimization are also forms of emotional abuse.

Neglect occurs when the caregiver does not try to respond to the older adult’s physical, emotional and social needs (housing, food, medication or access to adequate health care, including aspects such as therapeutic cruelty and therapeutic nihilism).

Abandonment (leaving an older adult who needs help alone without planning for his/ her care) is also a type of neglect.

Financial abuse happens when someone steals money or belongings from an older adult (retirement, Social Security benefits, etc.), uses his/her bank accounts or credit cards or changes names on a bank account, insurance policy, house title or will without permission.

 

Longevity and inequality

Inequality determines the way we age and is also in the roots of elder abuse.

According to a 2008 report of the Organization for Economic Cooperation and Development (OECD), “the increase in life expectancy” was concentrated “in populations continuing on to higher education” and diminished “in the groups having high school diplomas or less”.

In the OECD countries, a 25 year male with a university degree may live 7,5 years more than another male with lower education level. For women, the difference is 4,6 years. It goes without saying that inequality in education and any other development indicator is worse in the “emerging economies”.

Gender is also an inequality and abuse trigger, especially at old age. In 2015, 54% of people above 60 were women (61% within those aged 80 or more). Although female life expectancy is higher, their life quality is worse because of poor health and higher rates of abuse.

During their lifetimes, women suffer marginalization and poverty. Income inequality, differences in education, health services and job market explain why many women have no retirement benefits or lower ones. Moreover, they are the principal caregivers to children and other old people, often without any compensation.

 

The gap between the narratives and the facts

The United Nations expects an increase in elder abuse because of the ageing populations: the global population of people aged 60 years and older will more than double, from 900 million in 2015 to 2 billion in 2050.

During the COVID-19 pandemic rates of elder abuse have increased. Both the poor access to adequate health services and the restriction on social interactions have severely affected the elderly.

Neither population ageing nor elder abuse are new. There are countless initiatives, campaigns, plans and organizations around the globe trying to bring ageing into the public agenda, but real transformations are yet to come.

This year, WEAAD coincides with two important events. The first is the United Nations Decade of Healthy Ageing (2021-2030), aimed to align the goals of the 2030 Agenda and the ageing agenda.

 

The Decade addresses four areas for action:

– Change how we think, feel and act towards age and ageing;

– Ensure that communities foster the abilities of older people.

– Deliver person-centred integrated care and primary health services responsive to older people.

– Provide access to long-term care for older people who need it.

The second event is the 20th milestone of the Second World Assembly on Ageing and the fourth review and appraisal of the implementation of the Madrid International Plan of Action on Ageing (MIPAA).

UN believes that “an international legal instrument for older persons would advance the implementation and accountability of MIPAA”, and admits the “uneven progress” in its implementation and “the absence of an international standard on the rights of older persons, gaps between policy and practice, and the mobilization of necessary human and financial resources”.

 

When the conquest becomes the problem

Between 2015 and 2030 the world population aged 60 or over is expected to grow by 56%, reaching 1.4 billion people in 2030 (16,5% of the total population).

By then, “older persons are expected to account for over 25 percent of the population in Europe and Northern America, 17 percent in Asia and in Latin America and the Caribbean, and 6 percent in Africa” (UNDP).

The mainstream narrative that labels groups of population as a nuisance —migrants, women, indigenous people, the elderly… the list is open— denying their humanity and emphasizing that they put “the system” at risk, makes it possible for this violence to be perpetuated.

Moreover, in the current context of questioning the role of the State and the public sector, it is worth asking whether it is possible to guarantee good treatment of the elderly when what is at stake is no longer the viability of the systems of health and social protection necessary for a long-lived population, but even its mere existence for anyone.

María Isabel Cartón is a Spanish journalist, specialized on ageing issues. She is an active member of Asociación Jubilares, an NGO that promotes the social participation of senior citizens, and works within the WHO Global Network for Age-friendly Cities and Communities

Disability Inclusion Lifts Rural Ugandan Families From Poverty

Lawrence Akena had never dreamt of owning a cow. BRAC believes ownership of assets like livestock can get people out of extreme poverty. Credit: Wambi Michael/IPS

Lawrence Akena had never dreamt of owning a cow. BRAC believes ownership of assets like livestock can get people out of extreme poverty. Credit: Wambi Michael/IPS

By Wambi Michael
Oyam & Gulu, Uganda , Jun 14 2022 – Lawrence Akena was born 32 years ago with microcephaly. Because of his neurological condition, he didn’t go to school or benefit from skills training.

The exclusion meant Akena survived on handouts and was one of the young persons living in extreme poverty in Kamdini sub-county, Uganda.

“He would leave home early morning for Kamdini corner just to loiter in the township. At times he would spend nights there until I picked him (up and brought him) back,” says Akena’s mother, Lili Iram.

Akena’s condition, microcephaly, affects children born with a small head or a head that stops growing after birth. It can result in epilepsy, cerebral palsy, learning disabilities, hearing loss and vision problems.

The 76-year-old mother says things have changed now. BRAC, the largest NGO in the Global South, selected him among persons with disabilities to benefit from Disability Inclusive Graduation (DIG) project.

BRAC Uganda, the National Union of Women with Disabilities of Uganda (NUWODU), and Humanity & Inclusion (HI, formerly Handicap International) have implemented DIG in selected districts in once war-torn Northern Uganda since 2018. UK Aid has funded DIG through the Inclusive Futures initiative, Cartier Philanthropy and Medicor Foundation, and Sight Savers.

DIG is designed to ensure that Graduation’s four key elements, including meeting people’s basic needs, providing training and assets for income generation, financial literacy and savings support, and social empowerment, are adapted to ensure inclusion for persons with disabilities.

BRAC supported Akena with primary livelihood assets like goats, cattle, pigs, and cash for petty trade. Humanity & Inclusion and NUWODU ensured that DIG’s services, including coaching, were effectively designed to support people with disabilities.

Ownership and control mean that people with disabilities, like Akena, can create a pathway out of extreme poverty and become socially included.

“DIG has helped us a lot. We did not own a cow. We didn’t have goats and chickens. Akena is (now) always at home looking after them,” Imran says when asked about how the program affected her son.

As Imran describes her son’s transformation, Akena enters the loading shed to set his goats free so they can graze alongside two brown zebu cows. According to Iram, he suffered a major setback when his pigs died of African Swine Fever last year.

But when IPS visited Iceme village, where he lives with his mother, Akena had bought another pig which now lives in the pigsty he constructed.

BRAC Project Assistant, Derick Baguma visits Lawrence Akena and his mother Lili Iram regularly to assist with their farming ventures. Credit: BRAC

BRAC Project Assistant, Derick Baguma visits Lawrence Akena and his mother, Lili Iram, to assist with their farming ventures. Credit: BRAC

By owning the household assets like cows, goats, and chickens, Akena is graduating from the extremely poor,” says Derick Baguma, a Project Assistant with BRAC.

Baguma has provided household-based coaching to persons with disabilities in Iceme and other villages in Oyam’s Kamdini sub-county to record their assets.

Asked by IPS whether he had witnessed any changes, he said the difference was visible.

“This is not how this household was. And the way Akena appears now is not the same as he was. Do you see those shelters for goats and pigs? Lawrence Akena made over 80% of the contribution to ensure they are the way they are,” Baguma says. “And yet this is a person who was spending nights at verandas in Kamdini.”

Iram told IPS that she is working hard to ensure the assets multiply so that she can invest for her son’s future survival. She and her son are regular savers in their Village Saving Loan Association (VSLA), an informal, local financial institution that relies on its members’ savings to provide loans for emergencies and to support members’ enterprises.

“I had always wished to do something for my son, but I had no support. I plan to buy a piece (of land) and plant trees for his future from the savings in our village saving box,” she says.

Asked what lessons there were to learn from the DIG model, Baguma, who lives with Down syndrome, said there was a need for extra support for households with persons with disabilities.

“That when you are designing a project, you should include persons with disabilities. And it is possible. We shouldn’t look at the expenses. At times people say it is expensive. But we should look at the end results. How impactful is it going to be? If you don’t bring in that perspective of disability, then you are not reaching every person,” he said.

Uganda’s Ministry of Gender, Labour and Social Development 2020 study found that households with a person with a disability spent close to 39 percent more than other households.

“Future interventions to address poverty and wellbeing needs to ensure that the gap does not widen, leaving people with disabilities and their families behind. This may, therefore, necessitate the provision of additional resources to those households,” said the report.

Finding innovative solutions allows people living with a disability to support themselves and their families. Credit: BRAC

Finding innovative solutions allows people living with a disability to support themselves and their families. Credit: BRAC

DIG has also provided rehabilitation, psychosocial support (PSS) needs and assistive devices for persons with disabilities, such as railings for entryways, modified latrines and artificial limbs.

One of such recipients is Denis Aboke, who lives in the village next to Akuna’s. Aboke, a cancer survivor, says that he now has an artificial limb 18 years after losing his leg to cancer.

He told IPS that without DIG’s intervention, he would still be using wooden crutches.

“Amputation from cancer had rendered me completely useless. I could not go into the garden. Now I can do some farming. I’m now able to support my family. The children are going to school,” he says.

Apart from the primary assets,  Aboke also received a diesel-powered grain milling machine as part of the DIG program, earning him extra income from fellow villagers. While Aboke sees a brighter future for himself, he hopes to see organisations continue to support people with disabilities.

“My brother, I can tell you that nobody cares about people with disabilities. Landmines disabled many people, but there was no support. Health centres here have nothing to offer,” shares Aboke.

Rwot Ma Miyo Village Savings Loan Association members meeting. BRAC ensures that meetings take place at residences of persons with disabilities, so they can be included. Credit: Wambi Michael/IPS

Rwot Ma Miyo Village Savings Loan Association members meeting. BRAC ensures that meetings take place at residences of persons with disabilities, so they can be included. Credit: Wambi Michael/IPS

Aboke’s rehabilitation was performed at Gulu Regional Referral Hospital, over 65 kilometres from his village. The hospital’s orthopaedic workshop serves clients from Northern Uganda and South Sudan.

Principle Orthopaedic Technologist Senvume Kavuma Abbey told IPS that the workshop is overwhelmed by demand, yet orthopaedic care services are least funded in Uganda.

“The government last supplied us with materials ten years ago. So, if DIG had not come in, we wouldn’t be able to provide services to those who benefitted,” explains Senvume.

Program staff arranged community outreach visits linking orthopaedic services with people with different forms of disabilities.

“We were able to see where those people were coming from, and so we designed appliances customised to their environment and their nature of work, and what they desire to do,” said Senvume

While the DIG model is relatively new to Uganda, the program partners think it can be adopted elsewhere as a tool for improving livelihoods for people with disabilities.

Shammah Arinaitwe, a Technical Specialist with BRAC Uganda, told IPS that Graduation is good for reaching poor households. She explained that it considers the recipient’s needs and what they can do and uses their experience to forge the path out of poverty.

“I will give an example. If you cannot afford 60-70 cents of a dollar per day, the project gives you a boost,” explains Arinaitwe. The comparison of someone who has benefitted from DIG is that the assets gained through their participation in the project mean they end up being able to support themselves and grow.

“If I have one cow, eleven goats, and thirty chickens, you can’t compare me with someone who does not have any,” explains Arinaitwe. “I’m glad to tell you that the same model of the project is being started in Tanzania, drawing from the lessons from Uganda.”

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy

MARLTON, N.J., June 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial–stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer Smart Mini device were recently completed in Italy. The company announced the launch of the new technology on April 29, 2022, and the first U.S. implants on May 10, 2022.

Dr. Stefano Guarracini, Head of Cardiology at the Synergo Casa di Cura Pierangeli Hospital in Pescara, Italy, described his experience with CCM therapy and his outlook for the Optimizer Smart Mini system after the first implant. "Starting in 2019, we had the opportunity to implant Optimizer devices in several patients with heart failure. We believe in the technology and consider CCM therapy to be the only option for many patients suffering from heart failure. We are excited now to be affiliated with the first European institution to have implanted the new Optimizer Smart Mini device and look forward to the simple but more advanced patient management experiences during implants and follow–ups going forward."

Dr. Giovani Bisignani, with the Ospedale di Castrovillari, who completed his first implant almost simultaneously in the southern Italian province of Cosenza, said, "CCM therapy is a powerful weapon against heart failure. The cutting–edge technology of the new Optimizer Smart Mini along with its smaller, physiological shape allowed us to achieve efficient implantation and initiation of CCM therapy in even less time."

In March 2022, the company announced that its quality management system received certification under the new European Union Medical Device Regulation. We believe that the launch of the Optimizer Smart Mini system is an example of the importance of a global infrastructure to support ongoing technology innovation and access. The new components of the Optimizer Smart Mini system are equally important across international markets, including a rechargeable battery with a 20–year life and new internal technology with improved programming and potential for remote monitoring in a smaller design to make the implant procedure easier for patients and physicians.

"The pace of this international rollout is a reflection of our commitment to delivering innovation that is relevant to patients worldwide," said Mateusz Zelewski, MD, Impulse Dynamics' Vice President International, "It is exciting to see how quickly we can increase access to new and better technology that offers hope for more patients living with heart failure."

The Optimizer Smart Mini delivers CCM therapy, which consists of electric pulses applied to the heart between heartbeats and serves to enhance the performance of cardiac muscular contraction, making the heart work more efficiently without increasing the heart rate or the oxygen consumption of the cardiac muscle. CCM therapy is currently indicated in Europe to reduce hospitalizations and improve physical exercise tolerance, quality of life, and functional status for a large population of patients with systolic heart failure who remain symptomatic despite guideline–directed medical therapy.

To date, CCM therapy has already been used to treat over 7,000 patients worldwide and is available in 44 countries across the globe. The therapy has been studied in almost 2,000 patients and has appeared in more than 100 peer–reviewed journal articles. Ongoing studies are also underway to examine the safety and efficacy of CCM for patients suffering from heart failure with a left ventricular ejection fraction between 40 "" 60%.

About Impulse Dynamics

Impulse Dynamics is dedicated to helping healthcare providers enhance the lives of people with heart failure by transforming how the condition is treated. The company is focused on delivering its proprietary CCM therapy, which is delivered by the company's Optimizer Smart device, the CE–marked, and FDA–approved treatment verified to improve the quality of life for heart failure patients. CCM therapy is a safe, effective, and minimally invasive treatment option for many heart failure patients who otherwise have few effective options available to them.[1] To learn more, visit www.ImpulseDynamics.com, or follow the company on LinkedIn, Twitter, and Facebook.

Forward–looking Statements

This press release contains forward–looking statements. All statements other than statements of historical facts contained in this press release are forward–looking statements. In some cases, you can identify forward–looking statements by terms such as ""may,'' ""will,'' ""should,'' ""expect,'' ""plan,'' ""anticipate,'' ""could,'' ""intend,'' ""target,'' ""project,'' ""contemplate,'' ""believe,'' ""estimate,'' ""predict,'' ""potential'' or ""continue'' or the negative of these terms or other similar expressions, although not all forward–looking statements contain these words. Forward–looking statements include, but are not limited to, statements concerning potential benefits of CCM therapy, and the absence of risks associated therewith; the ability for CCM therapy and our products to fill a significant unmet medical need for patients with heart failure; and the short–term and long–term benefits of the Optimizer Smart Mini and CCM therapy in patients with heart failure, as well as to the physicians treating those patients. These forward–looking statements are based on management's current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward–looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the company's future research and development costs, capital requirements and the company's needs for additional financing; commercial success and market acceptance of CCM therapy; the company's ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer Smart and Optimizer Smart Mini systems or any future products the company may seek to commercialize; competitive companies and technologies in the industry; the company's ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the company's business model and strategic plans for its products, technologies and business, including its implementation thereof; the company's ability to expand, manage and maintain its direct sales and marketing organization; the company's ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the company's ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The company does not undertake any obligation to update forward–looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward–looking statements contained herein. These forward–looking statements should not be relied upon as representing the company's views as of any date subsequent to the date of this press release.

###


[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494150/

Attachments